Table 2.
Blood metabolites and intracellular phenylalanine
| Baseline | Exercise | 1 hr Post | 2 hr Post | ||
|---|---|---|---|---|---|
| Male | Blood flow (ml • min−1 • 100mg of leg LM−1) | 4.40 ± 0.1 | 17.17 ± 2.1* | 5.90 ± 0.8 | 4.82 ± 0.5 |
| Glucose concentration (mg • dl−1) | |||||
| Femoral artery | 94 ± 2 | 107 ± 5*b | 96 ± 3 | 92 ± 3 | |
| Femoral vein | 93 ± 2 | 104 ± 5*b | 94 ± 3 | 88 ± 3 | |
| Lactate (mmol • L−1) | |||||
| Femoral artery | 0.75 ± 0.1 | 9.95 ± 0.9*b | 2.12 ± 0.3 | 0.86 ± 0.1 | |
| Femoral vein | 0.80 ± 0.1 | 12.10 ± 0.9*† | 2.31 ± 0.2* | 1.00 ± 0.1 | |
| Blood pH | |||||
| Femoral artery | 7.41 ± 0.01 | 7.31 ± 0.01* | 7.40 ± 0.01 | 7.41 ± 0.01 | |
| Femoral vein | 7.37 ± 0.01 | 7.17 ± 0.01*b | 7.36 ± 0.01 | 7.37 ± 0.01 | |
| Phenylalanine concentration (μmol • L−1) | |||||
| Femoral artery | 54 ± 2 | 56 ± 2 | 54 ± 2 | 54 ± 1 | |
| Femoral vein | 58 ± 2 | 57 ± 2 | 58 ± 2 | 57 ± 2 | |
| Muscle intracellular | 78 ± 5 | 86 ± 6* | 76 ± 5 | 64 ± 3 | |
| Female | Blood flow (ml • min−1 • 100mg of leg LM−1) | 5.10 ± 0.8 | 18.34 ± 3.5* | 7.50 ± 1.0 | 6.81 ± 1.0 |
| Glucose concentration (mg • dl−1) | |||||
| Femoral artery | 88 ± 2 | 98 ± 3* | 89 ± 2 | 87 ± 2 | |
| Femoral vein | 86 ± 2 | 95 ± 3* | 86 ± 3 | 83 ± 3 | |
| Lactate (mmol • L−1) | |||||
| Femoral artery | 0.64 ± 0.1 | 8.21 ± 0.5* | 1.94 ± 0.2 | 0.7 ± 0.1 | |
| Femoral vein | 0.68 ± 0.1 | 9.68 ± 0.6* | 2.21 ± 0.2a | 0.89 ± 0.1 | |
| Blood pH | |||||
| Femoral artery | 7.41 ± 0.01 | 7.32 ± 0.01* | 7.39 ± 0.01 | 7.40 ± 0.01 | |
| Femoral vein | 7.37 ± 0.01 | 7.20 ± 0.01* | 7.36 ± 0.01 | 7.36 ± 0.01 | |
| Phenylalanine concentration (μmol • L−1) | |||||
| Femoral artery | 54 ± 4 | 56 ± 4 | 54 ± 4 | 53 ± 4 | |
| Femoral vein | 59 ± 4 | 58 ± 5 | 58 ± 6 | 57 ± 4 | |
| Muscle intracellular | 73 ± 3 | 85 ± 3* | 68 ± 2 | 63 ± 4 | |
P<0.05 vs. Baseline;
P<0.05 vs. Female;
P<0.1 vs. Baseline;
P<0.1 vs. Female.